SGD Pharma
Greenhouse gas emissions & sustainability report data
Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2022 | 217.1K tCO2e/year (Scope 1 & 2) |
| 2021 | 204.2K tCO2e/year (Scope 1 & 2) |
| 2018-2019 | 134.6K tons of CO2 (2018) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Awarded a gold EcoVadis sustainability rating, placing them in the top 5% of glass product manufacturers.
- 79% of all waste recycled.
- Plans to cut CO2 scope 1 and 2 emissions by 35% by 2030 and by 65% by 2040 (compared with a 2020 baseline).
- Renovation of a furnace at the Saint Quentin Lamotte plant in France, contributing to a two-thirds reduction in total carbon emissions by 2040 and cutting SQLM CO2 emissions by almost 20%.
- Joined the Science Based Targets initiative (SBTi).
🎯 Climate & Sustainability Targets
📅 Medium-term
- Cut CO2 scope 1 and 2 emissions by 35% by 2030
🔭 Long-term
- Reduce emissions by 65% by 2040
🌱 ESG Focus Areas
DecarbonizationSustainable ComplianceSustainable H&S and HR practices